Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2007

01-07-2007 | Case Reports/Clinical Vignettes

Health-Behavior Induced Disease: Return of the Milk-Alkali Syndrome

Authors: Joseph B. Caruso, MD, Rajendrakumar M. Patel, MD, Karan Julka, MD, David C. Parish, MD, FACP

Published in: Journal of General Internal Medicine | Issue 7/2007

Login to get access

Abstract

The milk-alkali syndrome is a well-documented consequence of excessive calcium and alkali intake first recognized in association with early 20th century antacid regimens. The syndrome became rare after widespread implementation of modern peptic ulcer disease therapies. With recent trends in osteoporosis therapy coupled with widely available calcium-containing supplements, the milk-alkali syndrome has reemerged as an important clinical entity. Our case illustrates a patient who self-medicated his peptic ulcer disease with a regimen resembling a common early 20th century dyspepsia regimen. When superimposed upon chronic high calcium supplementation, the patient became acutely ill from the milk-alkali syndrome. When taken to excess, or used inappropriately, medications and supplements ordinarily considered beneficial, can have harmful effects. Our case underscores the importance of obtaining a thorough medication history including use of over-the-counter supplementation.
Literature
1.
go back to reference Cooke AM. Alkalosis occurring in the alkaline treatment of peptic ulcers. Quart J Med. 1932;25:527. Cooke AM. Alkalosis occurring in the alkaline treatment of peptic ulcers. Quart J Med. 1932;25:527.
2.
go back to reference Sippy BW. Gastric and duodenal ulcer: medical cure by an efficient removal of gastric juice corrosion. JAMA. 1915;64:1625. Sippy BW. Gastric and duodenal ulcer: medical cure by an efficient removal of gastric juice corrosion. JAMA. 1915;64:1625.
3.
go back to reference Grundfast MB, Still CD, Komar MJ. Hypercalcemia and peptic ulcer disease-related milk-alkali syndrome. Nutr Clin Prac. 2003. Grundfast MB, Still CD, Komar MJ. Hypercalcemia and peptic ulcer disease-related milk-alkali syndrome. Nutr Clin Prac. 2003.
4.
go back to reference Gordon MV, Hamblin PS, McMahon LP. Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy. MJA. 2005;182(7):350–1.PubMed Gordon MV, Hamblin PS, McMahon LP. Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy. MJA. 2005;182(7):350–1.PubMed
5.
go back to reference Orwoll ES. The milk-alkali syndrome: current concepts. Ann Intern Med. 1982;97:242–8.PubMed Orwoll ES. The milk-alkali syndrome: current concepts. Ann Intern Med. 1982;97:242–8.PubMed
6.
go back to reference McMillan DE, Freeman RB. The milk alkali syndrome: a study of the acute disorder with comments on the development of the chronic condition. Medicine. 1965;44:485–501.PubMedCrossRef McMillan DE, Freeman RB. The milk alkali syndrome: a study of the acute disorder with comments on the development of the chronic condition. Medicine. 1965;44:485–501.PubMedCrossRef
7.
go back to reference Muldowney WP, Mazbar SA. Rolaids-yogurt syndrome: a 1990s version of milk-alkali syndrome. Am J Kidney Dis. 1996;27(2):270–2.PubMed Muldowney WP, Mazbar SA. Rolaids-yogurt syndrome: a 1990s version of milk-alkali syndrome. Am J Kidney Dis. 1996;27(2):270–2.PubMed
8.
go back to reference Beall DP, Scofield RH. Milk-alkali syndrome associated with calcium carbonate consumption. Medicine. 1995;74:89.PubMed Beall DP, Scofield RH. Milk-alkali syndrome associated with calcium carbonate consumption. Medicine. 1995;74:89.PubMed
9.
go back to reference Jacobs TP, Bilezikian JP. Rare causes of hypercalcemia. J Clin Endocrinol Metab. 90(11):6316–22. Jacobs TP, Bilezikian JP. Rare causes of hypercalcemia. J Clin Endocrinol Metab. 90(11):6316–22.
10.
go back to reference Wu K, Chuang R, Wu FL, et al. The milk-alkali syndrome caused by betelnuts in oyster shell paste. Clin Toxicol. 1996;34(6):741–5. Wu K, Chuang R, Wu FL, et al. The milk-alkali syndrome caused by betelnuts in oyster shell paste. Clin Toxicol. 1996;34(6):741–5.
11.
go back to reference Norton SA. Betel: consumption and consequences. J Clin Endocrinol Metab. 1998;38(1):81–8, Jan. Norton SA. Betel: consumption and consequences. J Clin Endocrinol Metab. 1998;38(1):81–8, Jan.
12.
go back to reference Kallner G, Karlsson H. Recurrent factitious hypercalcemia. Am J Med. 1987;82:536–8.PubMed Kallner G, Karlsson H. Recurrent factitious hypercalcemia. Am J Med. 1987;82:536–8.PubMed
13.
go back to reference Frame B, Jackson G, Kleerekoper M, Rao D, DeLorenzo A, Garcia M. Acute severe hypercalcemia a la Munchausen. Am J Med. 1981;70:316–9.PubMed Frame B, Jackson G, Kleerekoper M, Rao D, DeLorenzo A, Garcia M. Acute severe hypercalcemia a la Munchausen. Am J Med. 1981;70:316–9.PubMed
Metadata
Title
Health-Behavior Induced Disease: Return of the Milk-Alkali Syndrome
Authors
Joseph B. Caruso, MD
Rajendrakumar M. Patel, MD
Karan Julka, MD
David C. Parish, MD, FACP
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0226-0

Other articles of this Issue 7/2007

Journal of General Internal Medicine 7/2007 Go to the issue

Case Reports/Clinical Vignettes

An Unusual Case of Cardiac Amyloidosis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.